Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Leerink Partners analyst David Risinger initiates coverage on Oruka Therapeutics (NASDAQ:ORKA) with a Outperform rating and ...
Leerink Swann analyst David Risinger initiates coverage on Oruka Therapeutics (NASDAQ:ORKA) with a Outperform rating and ann...
LifeSci Capital initiates coverage on Oruka Therapeutics (NASDAQ:ORKA) with a Outperform rating and announces Price Target of...
TD Cowen analyst Tyler Van Buren initiates coverage on Oruka Therapeutics (NASDAQ:ORKA) with a Buy rating.
Jefferies analyst Michael Yee initiates coverage on Oruka Therapeutics (NASDAQ:ORKA) with a Buy rating and announces Price T...
Wedbush analyst David Nierengarten initiates coverage on Oruka Therapeutics (NASDAQ:ORKA) with a Outperform rating and annou...
Oruka Therapeutics, Inc. ("Oruka") (NASDAQ:ORKA), a biotechnology company developing novel biologics designed to set a ...
